Metabotropic glutamate antagonists alone and in combination with morphine

Comparison across two models of acute pain and a model of persistent, inflammatory pain

Mitchell J. Picker, Dana Daugherty, Fredrick E. Henry, Laurence L Miller, Linda A. Dykstra

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The present study examined the effects of the mGluR1 antagonist JNJ16259685 (JNJ) and the mGluR5 antagonist 2-methyl-6-phenylethynylpyridine (MPEP) alone and in combination with morphine in two acute pain models (hotplate, warm water tail-withdrawal), and a persistent, inflammatory pain model (capsaicin). In the hotplate and warm water tail-withdrawal procedures, JNJ and MPEP were ineffective when administered alone. In both procedures, JNJ potentiated morphine antinociception. In the hotplate procedure, MPEP potentiated morphine antinociception at the highest dose examined, whereas in the warm water tail-withdrawal procedure MPEP attenuated morphine antinociception at a moderate dose and potentiated morphine antinociception at a high dose. For both JNJ and MPEP, the magnitude of this morphine potentiation was considerably greater in the hotplate procedure. In the capsaicin procedure, the highest dose of MPEP produced intermediate levels of antihyperalgesia and also attenuated the effects of a dose of morphine that produced intermediate levels of antihyperalgesia. In contrast, JNJ had no effect when administered alone in the capsaicin procedure and did not alter morphine-induced antihyperalgesia. The present findings suggest that the effects produced by mGluR1 and mGluR5 antagonists alone and in combination with morphine can be differentiated in models of both acute and persistent pain.

Original languageEnglish (US)
Pages (from-to)785-793
Number of pages9
JournalBehavioural Pharmacology
Volume22
Issue number8
DOIs
StatePublished - Dec 1 2011

Fingerprint

Excitatory Amino Acid Antagonists
Acute Pain
Morphine
Pain
Capsaicin
Water
(3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone

Keywords

  • 2-methyl-6-phenylethynylpyridine
  • JNJ16259685
  • acute pain
  • capsaicin
  • metabotropic glutamate antagonists
  • morphine
  • persistent pain
  • potentiation
  • rat

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Metabotropic glutamate antagonists alone and in combination with morphine : Comparison across two models of acute pain and a model of persistent, inflammatory pain. / Picker, Mitchell J.; Daugherty, Dana; Henry, Fredrick E.; Miller, Laurence L; Dykstra, Linda A.

In: Behavioural Pharmacology, Vol. 22, No. 8, 01.12.2011, p. 785-793.

Research output: Contribution to journalArticle

@article{37d8ce14501d4d1b92d4fd3a4a436e17,
title = "Metabotropic glutamate antagonists alone and in combination with morphine: Comparison across two models of acute pain and a model of persistent, inflammatory pain",
abstract = "The present study examined the effects of the mGluR1 antagonist JNJ16259685 (JNJ) and the mGluR5 antagonist 2-methyl-6-phenylethynylpyridine (MPEP) alone and in combination with morphine in two acute pain models (hotplate, warm water tail-withdrawal), and a persistent, inflammatory pain model (capsaicin). In the hotplate and warm water tail-withdrawal procedures, JNJ and MPEP were ineffective when administered alone. In both procedures, JNJ potentiated morphine antinociception. In the hotplate procedure, MPEP potentiated morphine antinociception at the highest dose examined, whereas in the warm water tail-withdrawal procedure MPEP attenuated morphine antinociception at a moderate dose and potentiated morphine antinociception at a high dose. For both JNJ and MPEP, the magnitude of this morphine potentiation was considerably greater in the hotplate procedure. In the capsaicin procedure, the highest dose of MPEP produced intermediate levels of antihyperalgesia and also attenuated the effects of a dose of morphine that produced intermediate levels of antihyperalgesia. In contrast, JNJ had no effect when administered alone in the capsaicin procedure and did not alter morphine-induced antihyperalgesia. The present findings suggest that the effects produced by mGluR1 and mGluR5 antagonists alone and in combination with morphine can be differentiated in models of both acute and persistent pain.",
keywords = "2-methyl-6-phenylethynylpyridine, JNJ16259685, acute pain, capsaicin, metabotropic glutamate antagonists, morphine, persistent pain, potentiation, rat",
author = "Picker, {Mitchell J.} and Dana Daugherty and Henry, {Fredrick E.} and Miller, {Laurence L} and Dykstra, {Linda A.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1097/FBP.0b013e32834d13a2",
language = "English (US)",
volume = "22",
pages = "785--793",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Metabotropic glutamate antagonists alone and in combination with morphine

T2 - Comparison across two models of acute pain and a model of persistent, inflammatory pain

AU - Picker, Mitchell J.

AU - Daugherty, Dana

AU - Henry, Fredrick E.

AU - Miller, Laurence L

AU - Dykstra, Linda A.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The present study examined the effects of the mGluR1 antagonist JNJ16259685 (JNJ) and the mGluR5 antagonist 2-methyl-6-phenylethynylpyridine (MPEP) alone and in combination with morphine in two acute pain models (hotplate, warm water tail-withdrawal), and a persistent, inflammatory pain model (capsaicin). In the hotplate and warm water tail-withdrawal procedures, JNJ and MPEP were ineffective when administered alone. In both procedures, JNJ potentiated morphine antinociception. In the hotplate procedure, MPEP potentiated morphine antinociception at the highest dose examined, whereas in the warm water tail-withdrawal procedure MPEP attenuated morphine antinociception at a moderate dose and potentiated morphine antinociception at a high dose. For both JNJ and MPEP, the magnitude of this morphine potentiation was considerably greater in the hotplate procedure. In the capsaicin procedure, the highest dose of MPEP produced intermediate levels of antihyperalgesia and also attenuated the effects of a dose of morphine that produced intermediate levels of antihyperalgesia. In contrast, JNJ had no effect when administered alone in the capsaicin procedure and did not alter morphine-induced antihyperalgesia. The present findings suggest that the effects produced by mGluR1 and mGluR5 antagonists alone and in combination with morphine can be differentiated in models of both acute and persistent pain.

AB - The present study examined the effects of the mGluR1 antagonist JNJ16259685 (JNJ) and the mGluR5 antagonist 2-methyl-6-phenylethynylpyridine (MPEP) alone and in combination with morphine in two acute pain models (hotplate, warm water tail-withdrawal), and a persistent, inflammatory pain model (capsaicin). In the hotplate and warm water tail-withdrawal procedures, JNJ and MPEP were ineffective when administered alone. In both procedures, JNJ potentiated morphine antinociception. In the hotplate procedure, MPEP potentiated morphine antinociception at the highest dose examined, whereas in the warm water tail-withdrawal procedure MPEP attenuated morphine antinociception at a moderate dose and potentiated morphine antinociception at a high dose. For both JNJ and MPEP, the magnitude of this morphine potentiation was considerably greater in the hotplate procedure. In the capsaicin procedure, the highest dose of MPEP produced intermediate levels of antihyperalgesia and also attenuated the effects of a dose of morphine that produced intermediate levels of antihyperalgesia. In contrast, JNJ had no effect when administered alone in the capsaicin procedure and did not alter morphine-induced antihyperalgesia. The present findings suggest that the effects produced by mGluR1 and mGluR5 antagonists alone and in combination with morphine can be differentiated in models of both acute and persistent pain.

KW - 2-methyl-6-phenylethynylpyridine

KW - JNJ16259685

KW - acute pain

KW - capsaicin

KW - metabotropic glutamate antagonists

KW - morphine

KW - persistent pain

KW - potentiation

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=80855130498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855130498&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e32834d13a2

DO - 10.1097/FBP.0b013e32834d13a2

M3 - Article

VL - 22

SP - 785

EP - 793

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 8

ER -